PCV74 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR THE PRIMARY PREVENTION OF VENOUSTHROMBOEMBOLISM IN PATIENTS UNDERGOINGTOTAL HIP ORTOTAL KNEE REPLACEMENT SURGERY
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66372-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)66372-3/fulltext
Title :
PCV74 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR THE PRIMARY PREVENTION OF VENOUSTHROMBOEMBOLISM IN PATIENTS UNDERGOINGTOTAL HIP ORTOTAL KNEE REPLACEMENT SURGERY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66372-3&doi=10.1016/S1098-3015(10)66372-3
First page :
Section Title :
Open access? :
No
Section Order :
207